IDXX Q3'26 Earnings: revenue estimate is 1.19B USD

What happened

IDEXX Laboratories will report Q3'26 results on November 02 before the market opens, with disclosure expected at 9:30 AM ET. The revenue estimate is 1.19 billion USD and the earnings per share estimate is 3.72 USD.

Confirmed

Global impact / market context

IDEXX beat both revenue and earnings per share estimates in the four prior quarters shown, so investors may expect another beat. Missing the 1.19 billion USD revenue estimate could weigh on the stock, which means the share price could fall.

Analyst inference

Reported revenue rose steadily across the four prior quarters shown, and each quarter also beat its revenue estimate. The Q3'26 estimate of 1.19 billion USD sits above the year-earlier reported figure but below the latest reported quarter, which means growth may be slowing.

Analyst inference

What to watch

1. Watch whether reported revenue reaches the 1.19 billion USD estimate, since each of the four prior quarters beat its revenue estimate, which means actual sales came in above forecasts. Confirmed
2. Watch whether earnings per share reaches the 3.72 USD estimate, since prior quarters beat EPS estimates, which means profit per share came in above analyst forecasts. Proposed
3. Watch whether revenue exceeds the year-earlier reported figure, since growth from that level would support the case that demand for IDEXX products remains steady. Analyst inference

Evidence

• Original source link unavailable